Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 2
1981 1
1983 1
1984 5
1985 16
1986 9
1987 17
1988 30
1989 38
1990 41
1991 62
1992 54
1993 58
1994 128
1995 75
1996 64
1997 69
1998 62
1999 85
2000 94
2001 98
2002 78
2003 92
2004 107
2005 124
2006 120
2007 175
2008 205
2009 185
2010 222
2011 216
2012 303
2013 304
2014 305
2015 336
2016 324
2017 327
2018 355
2019 366
2020 436
2021 379
2022 367
2023 318
2024 117

Text availability

Article attribute

Article type

Publication date

Search Results

6,179 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Immunodeficiency 84"
Page 1
Efficacy and Safety of Subcutaneous Belimumab in Systemic Lupus Erythematosus: A Fifty-Two-Week Randomized, Double-Blind, Placebo-Controlled Study.
Stohl W, Schwarting A, Okada M, Scheinberg M, Doria A, Hammer AE, Kleoudis C, Groark J, Bass D, Fox NL, Roth D, Gordon D. Stohl W, et al. Arthritis Rheumatol. 2017 May;69(5):1016-1027. doi: 10.1002/art.40049. Epub 2017 Apr 7. Arthritis Rheumatol. 2017. PMID: 28118533 Free PMC article. Clinical Trial.
In the belimumab group, both time to and risk of severe flare were improved (median 171.0 days versus 118.0 days; hazard ratio 0.51 [95% CI 0.35-0.74]; P = 0.0004), and more patients were able to reduce their corticosteroid dosage by 25% (to 7.5 mg/day) during weeks 40-52 (18.2% …
In the belimumab group, both time to and risk of severe flare were improved (median 171.0 days versus 118.0 days; hazard ratio 0.51 [95% CI …
Modelling the impact of treatment adherence on the transmission of HIV drug resistance.
Lai H, Li R, Li Z, Zhang B, Li C, Song C, Zhao Q, Huang J, Zhu Q, Liang S, Chen H, Li J, Liao L, Shao Y, Xing H, Ruan Y, Lan G, Zhang L, Shen M. Lai H, et al. J Antimicrob Chemother. 2023 Aug 2;78(8):1934-1943. doi: 10.1093/jac/dkad186. J Antimicrob Chemother. 2023. PMID: 37311203
Increasing coverage to 95% would reduce the above total new infections (deaths) by 18.85% (15.75%). Reducing adherence to below 57.08% (40.84%) would offset these benefits of increasing coverage to 95% in reducing infections (deaths). ...
Increasing coverage to 95% would reduce the above total new infections (deaths) by 18.85% (15.75%). Reducing adherence to below 57.08% (40. …
Performance-based financing for improving HIV/AIDS service delivery: a systematic review.
Suthar AB, Nagata JM, Nsanzimana S, Bärnighausen T, Negussie EK, Doherty MC. Suthar AB, et al. BMC Health Serv Res. 2017 Jan 4;17(1):6. doi: 10.1186/s12913-016-1962-9. BMC Health Serv Res. 2017. PMID: 28052771 Free PMC article. Review.
PBF improved coverage of antiretrovirals in pregnant women (RR 1.55, 95% CI 1.50 to 1.59), infants (RR 1.92, 95% CI 1.84 to 2.01), and adults (RR 1.74, 1.64 to 1.85). PBF reduced attrition (RR 0.84, 95% CI 0.74 to 0.96) and treatment failure (odds ratio 0.55, 95% CI …
PBF improved coverage of antiretrovirals in pregnant women (RR 1.55, 95% CI 1.50 to 1.59), infants (RR 1.92, 95% CI 1.84 to 2.01), an …
Establishment and evaluation of a CT-based radiomic model for AIDS-associated pulmonary cryptococcosis.
Zhang ZX, Mu XY, Yu J, Guan CS, Chen BD, Xie RM. Zhang ZX, et al. BMC Med Imaging. 2022 Oct 29;22(1):185. doi: 10.1186/s12880-022-00910-6. BMC Med Imaging. 2022. PMID: 36309647 Free PMC article. Clinical Trial.
The AUCs of intermediate radiologist in combination with the LR radiomic model for all lesions, nodular lesions and cavity lesions were 0.88, 0.84, and 0.9, respectively, which were the highest among all models and radiologists. ...
The AUCs of intermediate radiologist in combination with the LR radiomic model for all lesions, nodular lesions and cavity lesions were 0.88 …
Pregnancy-related venous thromboembolism and HIV infection.
Schapkaitz E, Libhaber E, Rhemtula H, Gerber A, Jacobson BF, Chauke L, Büller HR. Schapkaitz E, et al. Int J Gynaecol Obstet. 2021 Oct;155(1):110-118. doi: 10.1002/ijgo.13596. Epub 2021 Feb 12. Int J Gynaecol Obstet. 2021. PMID: 33448037
RESULTS: Prepartum risk factors associated with VTE included; medical comorbidities (odds ratios [OR] 5.32, 95% confidence intervals [CI] 1.82-15.56), human immunodeficiency virus (HIV) (OR 2.84, 95% CI 1.50-5.41), and hospital admission or immobility (OR 5.33, 95% …
RESULTS: Prepartum risk factors associated with VTE included; medical comorbidities (odds ratios [OR] 5.32, 95% confidence intervals [CI] 1. …
Prevalence of and risk factors for Human Immunodeficiency Virus (HIV) infection in entrants and residents of an Ethiopian prison.
Sahle ET, Amogne W, Manyazewal T, Blumenthal J, Jain S, Sun S, Young J, Ellorin E, Woldeamanuel H, Teferra L, Feleke B, Vandenberg O, Rey Z, Briggs-Hagen M, Haubrich R, McCutchan JA. Sahle ET, et al. PLoS One. 2023 Feb 9;18(2):e0271666. doi: 10.1371/journal.pone.0271666. eCollection 2023. PLoS One. 2023. PMID: 36758059 Free PMC article.
Most participants were young (median age of 26 years, IQR: 21-33), male (84%), single (61%), literate (89%), and urban residents (91%) without prior incarceration (96%). ...
Most participants were young (median age of 26 years, IQR: 21-33), male (84%), single (61%), literate (89%), and urban residents (91% …
Thyroid Function in Newly Diagnosed HIV-positive Patients.
Dutta SK, Kalita BC. Dutta SK, et al. J Assoc Physicians India. 2023 May;71(5):11-12. doi: 10.5005/japi-11001-0248. J Assoc Physicians India. 2023. PMID: 37355812
BACKGROUND: As of 2019, the highest prevalence of human immunodeficiency virus (HIV) in India is seen in the Northeastern states. ...RESULTS AND OBSERVATIONS: A total of 95 newly diagnosed HIV-positive patients fulfilling the inclusion and exclusion criteria of our study w …
BACKGROUND: As of 2019, the highest prevalence of human immunodeficiency virus (HIV) in India is seen in the Northeastern states. ... …
The effectiveness of home-based HIV counseling and testing on reducing stigma and risky sexual behavior among adults and adolescents: A systematic review and meta-analyses.
Feyissa GT, Lockwood C, Munn Z. Feyissa GT, et al. JBI Database System Rev Implement Rep. 2015 Jul 17;13(6):318-72. doi: 10.11124/jbisrir-2015-2235. JBI Database System Rev Implement Rep. 2015. PMID: 26455755 Review.
BACKGROUND: Human immunodeficiency virus counselling and testing is a critical and essential gateway to Human immunodeficiency virus prevention, treatment, care and support services. ...OBJECTIVES: The objective of this review was to determine the effectiveness of h …
BACKGROUND: Human immunodeficiency virus counselling and testing is a critical and essential gateway to Human immunodeficiency …
Incorrect diagnoses in patients with neutralizing anti-interferon-gamma-autoantibodies.
Wu UI, Wang JT, Sheng WH, Sun HY, Cheng A, Hsu LY, Chang SC, Chen YC. Wu UI, et al. Clin Microbiol Infect. 2020 Dec;26(12):1684.e1-1684.e6. doi: 10.1016/j.cmi.2020.02.030. Epub 2020 Feb 28. Clin Microbiol Infect. 2020. PMID: 32120037 Free article.
OBJECTIVES: Early diagnosis of adult-onset immunodeficiency associated with neutralizing anti-interferon-gamma autoantibodies (anti-IFNgamma Abs) remains difficult given the lack of a distinctive phenotype and a routine test. ...RESULTS: Among the 154 patients enrolled, ne …
OBJECTIVES: Early diagnosis of adult-onset immunodeficiency associated with neutralizing anti-interferon-gamma autoantibodies (anti-I …
6,179 results